mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |